Dong-Guk Park

6PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 17, 2025
Current status of postoperative morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis: a prospective single-center observational study.

Jae Won Jo, Jung Wook Suh, Sung Chul Lee

|Oct 22, 2024
Oral reovirus reshapes the gut microbiome and enhances antitumor immunity in colon cancer.

Won Suk Lee, Seung Joon Lee, Hye Jin Lee

|Oct 14, 2023
Dual-Armed Oncolytic Myxoma Virus Encoding IFN-γ and CD47 Promotes Lymphocyte Infiltration and Tumor Suppression of Syngeneic Murine Melanoma.

Jong Kyu Woo, Tae-Geuk Kim, Na Yeon Im

|Jun 05, 2023
Comparison of genetic variation between primary colorectal cancer and metastatic peritoneal cancer.

Wonseok Shin, Jeongseok Yun, Kyudong Han

|Mar 22, 2023
YM155, specific survivin inhibitor, can enhance artesunate-induced cytotoxicity in HCT116 colon cancer cells.

Eui Tae Kim, Dong-Guk Park

|Oct 03, 2018
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer.

Dong-Wook Kim, Dong-Guk Park, Sanghyun Song

Pageof 1

Frequent Collaborators

1 joint publications

Nam-Hyuk Cho

1 joint publications

Tommy Alain

1 joint publications

Won Suk Lee

1 joint publications

Hannah Yang